Swiss National Bank decreased its position in shares of CIGNA Co. (NYSE:CI) by 1.1% in the fourth quarter, Holdings Channel reports. The fund owned 1,000,174 shares of the health services provider’s stock after selling 11,200 shares during the period. Swiss National Bank’s holdings in CIGNA were worth $203,125,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in CI. Cognios Capital LLC raised its position in shares of CIGNA by 15.1% during the fourth quarter. Cognios Capital LLC now owns 13,508 shares of the health services provider’s stock valued at $2,742,000 after buying an additional 1,768 shares during the last quarter. California Public Employees Retirement System raised its position in shares of CIGNA by 5.1% during the fourth quarter. California Public Employees Retirement System now owns 694,509 shares of the health services provider’s stock valued at $141,048,000 after buying an additional 33,959 shares during the last quarter. M&T Bank Corp raised its position in shares of CIGNA by 11.4% during the fourth quarter. M&T Bank Corp now owns 26,872 shares of the health services provider’s stock valued at $5,459,000 after buying an additional 2,749 shares during the last quarter. Community Bank N.A. acquired a new position in shares of CIGNA during the fourth quarter valued at about $186,000. Finally, Icon Advisers Inc. Co. raised its position in shares of CIGNA by 119.5% during the fourth quarter. Icon Advisers Inc. Co. now owns 54,437 shares of the health services provider’s stock valued at $11,056,000 after buying an additional 29,637 shares during the last quarter. 88.04% of the stock is owned by hedge funds and other institutional investors.

Shares of CIGNA Co. (NYSE:CI) opened at $193.77 on Friday. The firm has a market cap of $46,175.64, a PE ratio of 22.20, a P/E/G ratio of 1.14 and a beta of 0.45. CIGNA Co. has a 52 week low of $141.93 and a 52 week high of $227.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.37 and a quick ratio of 0.39.

CIGNA (NYSE:CI) last issued its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.94 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.87 by $0.07. The firm had revenue of $10.53 billion for the quarter, compared to analysts’ expectations of $10.28 billion. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.87 earnings per share. equities analysts expect that CIGNA Co. will post 12.9 EPS for the current year.

A number of brokerages have recently commented on CI. Oppenheimer upped their price objective on shares of CIGNA to $237.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. Morgan Stanley upped their price objective on shares of CIGNA to $255.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Goldman Sachs Group began coverage on shares of CIGNA in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $247.00 price objective for the company. ValuEngine raised shares of CIGNA from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Finally, Zacks Investment Research raised shares of CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price objective for the company in a research report on Friday, December 22nd. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. CIGNA has a consensus rating of “Buy” and an average price target of $210.12.

In other CIGNA news, Chairman Isaiah Harris, Jr. sold 212 shares of the company’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $209.35, for a total transaction of $44,382.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Donna F. Zarcone sold 5,971 shares of the company’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $215.43, for a total transaction of $1,286,332.53. The disclosure for this sale can be found here. Insiders have sold 75,080 shares of company stock worth $15,390,073 over the last ninety days. Insiders own 1.30% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/cigna-co-ci-shares-sold-by-swiss-national-bank/1857940.html.

CIGNA Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.